[Cytomegalovirus reactivation in patients with immune-mediated gastritis]

Enferm Infecc Microbiol Clin (Engl Ed). 2023 May;41(5):298-300. doi: 10.1016/j.eimce.2022.03.017. Epub 2023 Jan 19.
[Article in Spanish]

Abstract

Introduction: Reactivation of cytomegalovirus can complicate the evolution of patients with gastritis induced by immune checkpoint inhibitors.

Methods: The experience in our center is described and a review of the literature is performed.

Results: A case of severe gastritis induced by treatment with a programmed cell death receptor-1 (anti-PD1) inhibitor, associated with reactivation of cytomegalovirus (CMV) is described. In the systematic review, we identified 5 cases of immune-related gastritis associated with CMV reactivation. Ganciclovir treatment contributed to clinical improvement in most patients.

Conclusion: The early identification of a CMV infection in patients with severe or refractory immune-related gastritis will allow the initiation of targeted treatment, and may avoid increasing immunosuppressive therapy.

Keywords: Citomegalovirus; Cytomegalovirus; Gastritis; Immune checkpoint inhibitor; Immunotherapy; Inhibidor del punto de control inmunitario; Inmunoterapia.

Publication types

  • Review
  • Case Reports
  • English Abstract

MeSH terms

  • Cytomegalovirus / physiology
  • Cytomegalovirus Infections* / complications
  • Ganciclovir / therapeutic use
  • Gastritis* / complications
  • Gastritis* / drug therapy
  • Humans

Substances

  • Ganciclovir